Dr. Jacqueline Rochelle Douge, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8930 Stanford Blvd, Columbia, MD 21045 Phone: 410-313-7569 |
Theresa Elaine Bourne, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8821 Columbia 100 Pkwy, Columbia, MD 21045 Phone: 410-997-1700 Fax: 410-740-8315 |
Dr. Angela M Tamayo, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 7070 Samuel Morse Dr, Kaiser Permanente Medical Center, Columbia, MD 21046 Phone: 410-309-4646 |
News Archive
A commonly used medication that prevents blood clots from forming may also prevent existing clots from damaging delicate vein walls and may accelerate healing in a clot-damaged area of vein wall, according to new research from the University of Michigan Cardiovascular Center.
The U.S. Food and Drug Administration announced today that U.S. Marshals, at the agency's request, seized nearly 90,000 bottles of dietary supplements labeled as containing kratom. The product, manufactured for and held by Dordoniz Natural Products LLC, located in South Beloit, Illinois, is marketed under the brand name RelaKzpro and worth more than $400,000.
Russia should increase efforts to address HIV/AIDS among injection drug users to slow the spread of the disease, UNAIDS Executive Director Peter Piot said on Saturday during a conference on HIV/AIDS in the former Soviet Union, Reuters reports. According to Reuters, the former Soviet Union has the third-highest number of people living with HIV/AIDS worldwide.
Headaches, a virtually universal human complaint at one time or another, are among the top reasons for medical evacuation of military personnel from Iraq and Afghanistan, and for ongoing depletion of active-duty ranks in those countries, according to research led by Johns Hopkins specialists. Just one-third of soldiers sent home because of headaches return to duty in either place, the research shows.
Infinity Pharmaceuticals, Inc. today reported preclinical data for IPI-145, the company's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma. The data demonstrate potent PI3K-delta and -gamma inhibition in biochemical, cellular and whole blood assays and activity in multiple preclinical models of inflammatory disease, including rheumatoid arthritis and asthma.
› Verified 6 days ago